Get the content you want anytime you want.

Top 5 Contagion® News Articles for the Week of October 1, 2017


#3: What's Hot in Infectious Disease and HIV Science

Basic and clinical research on infectious disease and HIV continued at a brisk pace in the past year. As outlined by 4 speakers at a symposium at the annual ID Week conference in San Diego, California, real advances were made.

A hot clinical topic for a long time in infectious diseases has been multidrug resistance (MDR). Now, according to Stan Deresinski, MD, Stanford University, Palo Alto, California, “the great fear has come true.” A report last year from China described deaths due to hypervirulent and carbapenem-resistant Klebsiella pneumonia (ST11). The report once again highlights the need for an expedited pathway for antibiotic development and approval.

Read more about hot topics in infectious disease and HIV science, here

#2: New Report Outlines Lyme Disease Management in the UK

In an effort to better diagnose and treat cases of Lyme disease, the United Kingdom’s National Institute for Health and Care Excellence (NICE) has issued a draft guidance to help general practitioners and health professionals better spot cases of the tick-borne disease.

Lyme disease is transmitted to humans through the bites of black-legged ticks infected with Borrelia burgdorferi. Although most ticks don’t carry the bacteria that causes Lyme disease, bites from infected ticks can lead to initial symptoms including fever, headache, fatigue, and a telltale “bullseye” skin rash. Infections are treated with antibiotics such as doxycycline or amoxicillin. According to the Centers for Disease Control and Prevention (CDC), if left untreated, more serious symptoms can develop, including severe headaches and neck stiffness, arthritis with severe joint pain and swelling, facial palsy, heart palpitations, and inflammation of the brain and spinal cord. In the United States, the geographical distribution of Lyme disease has been growing, and the disease has also been reported in forested areas of Asia and Europe according to the World Health Organization (WHO).

Read more about the report, here.

Big advances in treatment can